Candriam SCA’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-144,428
| Closed | -$21M | – | 915 |
|
|
2022
Q2 | $21M | Buy |
+144,428
| New | +$21M | 0.17% | 131 |
|
|
2021
Q4 | – | Sell |
-47,005
| Closed | -$6.53M | – | 927 |
|
|
2021
Q3 | $6.53M | Hold |
47,005
| – | – | 0.04% | 346 |
|
|
2021
Q2 | $4.56M | Sell |
47,005
-2,062
| -4% | -$200K | 0.03% | 422 |
|
|
2021
Q1 | $4.04M | Hold |
49,067
| – | – | 0.03% | 410 |
|
|
2020
Q4 | $4.21M | Sell |
49,067
-107,820
| -69% | -$9.24M | 0.03% | 421 |
|
|
2020
Q3 | $10.2M | Sell |
156,887
-15,912
| -9% | -$1.03M | 0.1% | 228 |
|
|
2020
Q2 | $12.6M | Sell |
172,799
-16,000
| -8% | -$1.17M | 0.13% | 178 |
|
|
2020
Q1 | $10M | Hold |
188,799
| – | – | 0.11% | 211 |
|
|
2019
Q4 | $10.3M | Sell |
188,799
-231,000
| -55% | -$12.6M | 0.11% | 213 |
|
|
2019
Q3 | $17.5M | Sell |
419,799
-38,000
| -8% | -$1.59M | 0.23% | 94 |
|
|
2019
Q2 | $20M | Buy |
457,799
+15,000
| +3% | +$654K | 0.25% | 90 |
|
|
2019
Q1 | $22.8M | Sell |
442,799
-105,000
| -19% | -$5.4M | 0.29% | 77 |
|
|
2018
Q4 | $20.3M | Buy |
547,799
+130,500
| +31% | +$4.83M | 0.31% | 64 |
|
|
2018
Q3 | $15.7M | Buy |
417,299
+210,200
| +101% | +$7.89M | 0.21% | 115 |
|
|
2018
Q2 | $8.19M | Buy |
207,099
+102,099
| +97% | +$4.04M | 0.13% | 202 |
|
|
2018
Q1 | $2.71M | Buy |
105,000
+25,000
| +31% | +$644K | 0.05% | 414 |
|
|
2017
Q4 | $2.16M | Buy |
+80,000
| New | +$2.16M | 0.04% | 435 |
|